Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Latanoprost for Glaucoma
NCT01426464Phase 2Unknown
- Start
- Sep 2011
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in primary open-angle glaucoma (POAG). Status: unknown.
02
Drugs
latanoprost
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT01426464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426464.